Breast Cancer Index Test Data Reinforces Efficacy
Hologic and Biotheranostics unveiled new data showing that the Breast Cancer Index (BCI) test improves treatment decision-making.
Read MorePosted by Chris Wolski | May 28, 2025 | Breast |
Hologic and Biotheranostics unveiled new data showing that the Breast Cancer Index (BCI) test improves treatment decision-making.
Read MorePosted by Chris Wolski | May 28, 2025 | Infectious Diseases |
Rachel Burgoon developed a risk scoring tool to help physicians more effectively identify and treat drug-resistant infections.
Read MorePosted by Chris Wolski | May 23, 2025 | Urine Analyzers |
Vibrant Wellness has launched the Hormone Zoomer, a urine test providing analysis of hormone metabolism, endocrine disruptors, etc.
Read MorePosted by Chris Wolski | May 16, 2025 | Dementias & Alzheimer’s |
Alamar Biosciences has expanded its NULISAseq CNS Disease Panel 120 to include highly sensitive, blood-based assays.
Read MorePosted by Chris Wolski | May 14, 2025 | Allergy & Autoimmune |
A new peer-reviewed study validates Vibrant Sciences’ microarray, enabling fast, accurate, scalable detection of over 17 tickborne pathogens.
Read More